Decision No. 163/QD-QLD on the Promulgation of the List of 603 Domestically Manufactured Drugs Granted Marketing Authorization Extension in Vietnam – Phase 216
On April 4, 2025, the Drug Administration of Vietnam issued Decision No. 163/QD-QLD regarding the List of 603 domestically manufactured drugs that have been granted an extension of their marketing authorization in Vietnam – Phase 216.
The list includes:
- 395 domestically manufactured drugs granted a 5-year extension of marketing authorization,
- 175 domestically manufactured drugs granted a 3-year extension of marketing authorization, and
- 33 domestically manufactured drugs granted a marketing authorization extension valid until December 31, 2025.
